GlaxoSmithKline

GSK: 1,712.70 +12.90 (+0.76%) delayed: 18 Nov 2019, 16:02

Trade now
Bid Price 1,712.60 High Price 1,718.20
Ask Price 1,712.80 Low Price 1,690.00
Open Price 1,708.20 Spread 0.01%
Prev Close 1,699.80 Volume 3,104,550

GlaxoSmithKline Share Price

Intraday
Historic - 6 months
>> Advanced GlaxoSmithKline Charts >>

GlaxoSmithKline Share Price Information

Name GlaxoSmithKline
Epic GSK
Sector Pharmaceuticals
ISIN GB0009252882
Activites GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment. Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market. GSK also has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products. The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products and nutritional healthcare drinks, all of which are among the market leaders. GSK has over 100,000 employees worldwide. Of these, over 40,000 are in sales and marketing, the largest sales force in the industry. Around 35,000 employees work at 82 manufacturing sites in 37 countries and over 15,000 are in R&D. GSK R&D is based at 24 sites in 11 countries. The company has a leading position in genomics/genetics and new drug discovery technologies. The GSK R&D budget is about £2.8bn/$5bn.
Index FTSE 100
Latest Share Price (p) 1,712.70 Net Gearing (%) 87.00
Market Capitalisation (£m) 84,801.61 Gross Gearing (%) 93.68
Shares in issue (m) 4,988.92 Debt Ratio 89.68
P/E Ratio 23.06 Debt-to-Equity Ratio 0.59
Total dividends per share (p) 80.00 Assets / Equity Ratio 15.81
Dividend Yield (%) 4.71 Price to book value 23.09
Dividend Cover 0.92 ROCE (%) 13.49
Earning per share (p) 73.70 EPS Growth (%) 134.71
52-week high / low (p) 1,796.40 / 1,408.80 DPS Growth (%) 0.00

GlaxoSmithKline Broker Views

Date Broker Recommendation Price Old Target Price New Target Price Notes
18 Nov Barclays Capital Equal weight 1,711.90 1,650.00 - Reiterates
15 Nov Jefferies International Buy 1,711.90 1,850.00 - Reiterates
15 Nov Liberum Capital Hold 1,711.90 1,890.00 - Reiterates
08 Nov Citigroup Neutral 1,711.90 1,840.00 - Reiterates
07 Nov Citigroup Neutral 1,711.90 1,840.00 - Reiterates
>> More GlaxoSmithKline Broker Views >>

GlaxoSmithKline Director Deals

Date Director Type Volume / Price Trade Value
01 Nov 2019 Emma Walmsley Exercise 137,040 @ 1,203.50p £1,649,276.40
01 Nov 2019 Emma Walmsley Sale Post-Exercise 112,945 @ 1,775.88p £2,005,767.67
30 Oct 2019 Manvinder Banga Buy 417 @ 1,725.00p £7,193.25
30 Oct 2019 Dr Vivienne Cox Buy 308 @ 1,725.00p £5,313.00
30 Oct 2019 Jonathan Symonds Buy 834 @ 1,725.00p £14,386.50
>> More GlaxoSmithKline Director Deals >>

GlaxoSmithKline News

>> More GlaxoSmithKline News >>